Recent studies in our laboratory demonstrate that ligandmediated activation of the EphA8 receptor critically regulates cell adhesion and migration. In this report, we show that the EphA8 receptor induces neurite outgrowth in NG108-15 cells in the absence of ligand stimulation. Using various deletion mutants lacking specific intracytoplasmic regions, we confirm that the tyrosine kinase domain of EphA8 is important for inducing neurite outgrowth. However, the tyrosine kinase activity of EphA8 is not crucial for neurite outgrowth induction. Treatment with various inhibitors further reveals that the mitogen-activated protein kinase (MAPK) signaling pathway is critical for neurite outgrowth induced by EphA8. Consistent with these results, EphA8 expression induced a sustained increase in the activity of MAPK, whereas ligand-mediated EphA8 activation had no further modulatory effects on MAP kinase activity. Additionally, activated MAPK relocalized from the cytoplasm to the nucleus in response to EphA8 transfection. These results collectively suggest that the EphA8 receptor is capable of inducing a sustained increase in MAPK activity, thereby promoting neurite outgrowth in neuronal cells.
Introduction
The Eph receptor tyrosine kinases (RTKs), together with ephrin ligands, regulate diverse developmental patterning processes, including axon guidance, cell migration, and cell segregation (Schmucker and Zipursky, 2001; Wilkinson, 2001; Coulthard et al., 2002; Tepass et al., 2002; Himanen and Nikolov, 2003) . In contrast to other RTK families, Eph RTKs do not regulate cell proliferation and survival. Rather, activation of these RTKs by their cognate ligands leads to changes in cell adhesion to various extracellular matrix proteins (Mellitzer et al., 2000; Klein, 2001; Kullander and Klein, 2002) . Signaling molecules involved in Eph receptor-mediated modulation of cell adhesion may be important for analysing the mechanisms underlying cell migration, cell segregation, and axon guidance. However, the interactions among these signaling molecules are fairly complex, and it remains to be determined whether they play a pivotal role in axonal behavior and migration of physiologically relevant neurons that express Eph receptors or ephrin ligands.
Many studies suggest that the mitogen-activated protein kinase (MAPK) pathway is involved downstream of activated Eph receptors, although current data are inconsistent. For example, both EphA2 and EphB1 promote the MAPK signaling cascade through recruitment of the adapter proteins, Grb2 and Shc, when activated by ligand binding (Pratt and Kinch, 2002; Vindis et al., 2003) . Moreover, ligand-activated EphB1 interacts with Nck and Ste20 kinase NIK (Nckinteracting protein), thereby stimulating c-Jun NH 2 -terminal kinase (JNK) (Becker et al., 2000) . In contrast to these results, some studies indicate that specific Eph receptors negatively regulate an MAPK signaling pathway. For example, ligand-activated EphB2 inhibits Ras and MAPKs, thereby inducing neurite retraction in NG108-15 neuronal cells (Elowe et al., 2001) . In this signaling pathway, the binding of p120 RasGAP to EphB2 is important for downregulation of the Ras-MAPK cascade and neurite retraction. Moreover, the Ras-MAPK pathway is rapidly and potently suppressed by EphA2 kinase in response to ligand stimulation (Miao et al., 2001) . These discrepancies may be explained by several cell conditions, such as varying levels of protein expression, different cell types, assay conditions, and Eph genes used. A recent investigation on EphB2 demonstrates that elimination of all RasGAP-binding sites, accompanied by the addition of a Grb2-binding site, leads to activation of MAPKs, rather than downregulation, following ephrin-B1 stimulation (Tong et al., 2003) . This finding strongly suggests that distinct Eph receptors can transmit opposite signals to MAPK pathways via their ability to recruit distinct targets.
Previous reports by our group show that ligandactivated EphA8 recruits p110g PI-3 kinase in a tyrosine kinase activity-independent manner, thereby promoting cell adhesion and cell migration Park, 2001, 2003) . Here, we provide evidence for the first time that EphA8 induces a sustained increase in MAPK activation to promote neurite extension in mouse neuroblastoma Â rat glioma hybrid NG108-15 cells. Significantly, ligand stimulation and EphA8 autokinase activity are not required for EphA8-mediated MAPK activation. In contrast to our previous finding that the juxtamembrane region is critical for EphA8-promoted cell adhesion (Gu and Park, 2001) , data from this study indicate that the conserved tyrosine kinase domain is important for EphA8-induced MAPK activation and neurite outgrowth. Our findings suggest that the EphA8 receptor induces axonal projections through regulation of the MAPK signaling pathway.
Results

Induction of neurite outgrowth by EphA8 expression in NG108-15 cells
Mouse neuroblastoma Â rat glioma hybrid NG108-15 cells (Nelson et al., 1976) were transiently transfected with EGFP or EphA8-IRES-EGFP cDNA mixed with Lipofectamine, as described in Materials and methods. Cells were cultured on fibronectin-or BSA-coated cover glasses for 2 further days in the absence or presence of dibutyryl cAMP (dbcAMP). DbcAMP was used as a positive control to induce neurite outgrowth in NG108-15 cells. Very intense green fluorescence was observed, not only in soma, but also neurites of transfected cells, indicating that EGFP is an excellent marker for visualization of neurites sprouting from NG108-15 cells (Figure 1c ). The transfection efficiency varied from 20 to 30% in both vector-and EphA8-transfected cells, based on the relative numbers of GFP-positive cells. To directly assess whether the levels of EphA8 or EGFP are altered by dbcAMP treatment, immunoblot analysis was performed, as shown in Figure 1b The EGFP or EphA8-IRES-EGFP expression construct was transiently transfected into NG108-15 cells using Lipofectamine. At 24 h post-transfection, cells were cultured on fibronectin (FN) or BSA-coated coverslips in the presence or absence of dbcAMP for 2 days. Cells containing neurites exceeding three cell body diameters in length were counted as neurite-bearing cells. A total of at least 500 GFP-positive cells was scored in each condition. Data are presented as means7s.e. from at least three independent experiments. b , specific comparison between cells treated with or without dbcAMP (Po0.005).
c , specific comparison between cells transfected with EphA8-IRES-EGFP or a control EGFP vector (Po0.001). (b) Equal amounts of protein (100 mg) from each cell lysate sample were directly analysed by immunoblot analysis, using anti-EphA8 (top panel) or anti-GFP antibody as a probe (bottom panel). (c) Representative photographs of NG108-15 cells expressing EGFP with or without EphA8, described in panel a. Cells were cultured on fibronectin (left and middle panels) or BSA (right panels) in the presence or absence of dbcAMP as indicated, and examined by fluorescence microscopy. Scale bar equals 100 mm Next, we examined the effects of EphA8 expression on neurite outgrowth. A neurite was defined as a process extending at least three cell diameters from the cell body. As expected, upon dbcAMP treatment of EGFP-transfected cells, the percentage of neurite-bearing cells increased to 1775% (n (GFP-positive cells) ¼ 500) ( Figure 1a , lane 2). We also observed that the induction of neurite outgrowth by dbcAMP treatment was completely inhibited in the presence of PKA inhibitors (data not shown). This result is consistent with previous reports that dbcAMP is capable of inducing neurite outgrowth in NG108-15 cells by activating the cAMP/PKA pathway (Gendron et al., 2003) . Interestingly, even in the absence of dbcAMP, the percentage of EphA8-transfected cells with neurites (2076% (n ¼ 500)) was much higher than that in vector-transfected cells (Figure 1a , lane 3). Moreover, the percentage of cells with neurites was significantly more enhanced in cells expressing EphA8 in the presence of dbcAMP (3077% (n ¼ 500)) ( Figure 1a , lane 4), and long neurites (longer than 10 cell diameters) were frequently observed in these cells ( Figure 1c , middle and bottom panel). However, differences with regard to increase in the number of neurites per cell and branched neurites in EphA8-transfected cells were statistically not significant, compared with dbcAMPtreated cells with no EphA8 expression (data not shown). EphA8 expression in NG108-15 cells induced neurite outgrowth in fibronectin-coated, but not BSA-coated substratum ( Figure 1a , lanes 3 and 5), possibly consistent with previous reports that the EphA8 receptor crosstalks with the fibronectin receptor (Gu and Park, 2001 ).
Requirement of the EphA8 tyrosine kinase domain for inducing neurite outgrowth in NG108-15 cells
To investigate whether induction of neurite outgrowth by EphA8 is dependent on the signaling function of its intracytoplasmic region, we utilized a kinase-inactive mutant and four different deletion mutants lacking structural motifs of the EphA8 cytoplasmic domain or the globular ligand binding domain (Figure 2a ). The EphA8 K666M mutant is defective in tyrosine kinase activity due to the presence of Met in place of Lys 666, the putative ATP-binding residue (Gu and Park, 2001 ). The deleted portions of the murine EphA8 receptor correspond to a highly conserved juxtamembrane (JM) domain, a tyrosine kinase domain (KD), a sterile alpha motif (SAM), and an immunoglubuline-like (Ig) domain, respectively (Gu and Park, 2001 ). EphA8 mutants were transiently expressed, together with EGFP in NG108-15 cells. These mutants were expressed with the expected molecular masses (Figure 2c , second panel). An immunoblot with antiphosphotyrosine antibody revealed that both wild-type EphA8 and SAM domain deletion mutant were efficiently tyrosine phosphorylated in the absence of exogenous ligand stimulation ( Figure 2c , first panel, lanes 2 and 6). However, the kinase-dead K666M mutant, JM deletion mutant, KD deletion mutant, and Ig deletion mutant were not detectably tyrosine phosphorylated under the same transfection condition (Figure 2c , first panel, lanes 3-5 and 7). Cell surface-binding assay using ephrinA5-Fc protein revealed that all EphA8 proteins except for the globular domain deletion mutant effectively bound to ligand. This result suggests that all EphA8 cytoplasmic deletion mutants are effectively localized to the cell surface (Figure 2d) . Using EGFP visualization, we monitored whether each deletion or kinase-inactive mutant induces neurite outgrowth in transfected cells. As shown in Figure 2b , all EphA8 cytoplasmic deletion and kinase-inactive EphA8 mutants induced neurite outgrowth in NG108-15 cells, except the tyrosine kinase domain deletion mutant (lane 5). Strikingly, the globular ligand-binding domain-deleted EphA8 mutant induced neurite outgrowth as efficiently as wild-type EphA8 (lane 7). Taken together, our results imply that the tyrosine kinase domain of EphA8 is required for intracytoplasmic signaling, leading to neurite outgrowth in NG108-15 cells, although tyrosine kinase activity per se is not crucial for this signaling activity.
Involvement of MAPK signaling in EphA8-induced neurite outgrowth
We further investigated whether EphA8-induced neurite outgrowth in NG108-15 cells is mediated by well-known signaling pathways leading to the differentiation of neuronal cells. As shown in Figure 3a , various inhibitors blocking each specific pathway treated vector-or EphA8-transfected NG108-15 cells, and the number of neurite-bearing cells among EGFP-positive cells was counted. A PI-3 kinase inhibitor (Wortmannin) and cAMP/PKA pathway inhibitors (Rp-cAMP and 5-24) exerted no inhibitory effects on EphA8-induced neurite outgrowth in NG108-15 cells (Figure 3a) , although RpcAMP and 5-24 effectively blocked dbcAMP-induced neurite outgrowth in vector-transfected cells (data not shown). Interestingly, MEK-specific inhibitors such as PD98059 and U0126 markedly suppressed both EphA8-induced neurite outgrowth (Figure 3a , lanes 5-6) and MAPK activation (Figure 3b , third panel), suggesting that the MAPK-mediated pathway is critical for EphA8-induced neurite outgrowth. Immunoblot analysis depicted in Figure 3b confirmed stable and similar expression of EphA8, EGFP, or MAPKs, irrespective of inhibitor treatment, as compared to those observed following DMSO treatment (control).
To further establish that MAPK activation is involved in the signaling pathway leading to EphA8-induced neurite outgrowth, we utilized a dominantnegative MEK (MEK2A) expression construct for inhibition experiments (Yan and Templeton, 1994; Kuo et al., 1996) . As shown in Figure 4a and c, simultaneous expression of MEK2A and EphA8 markedly inhibited both EphA8-induced neurite outgrowth and MAPK activation, dependent on the amounts of transfected MEK2A cDNA. In contrast to MEK2A, MEK2E, constitutively active mutant of MEK1, induced neurite outgrowth as effectively as EphA8 did, and this effect was independent of ephrin-A5 stimulation (Figure 4b ). MEK2A expression did not significantly affect the relative levels of EphA8 in cotransfected cells (Figure 4c and d) . However, in NG108-15 cells, 2 mg MEK2A markedly suppressed EphA8 expression and displayed a cytotoxic effect in a transfection assay (data not shown). These results strongly suggest that MAPK activation is involved downstream of the EphA8 signaling pathway to induce neurite outgrowth in NG108-15 cells.
Sustained MAPK activation is induced by the expression of EphA8 with no requirement for ligand stimulation
Based on the possibility that MAPK is involved in EphA8-induced neurite outgrowth, we further investigated whether EphA8 activates MAPK in various cell types. NIH3T3 cells transiently transfected with an EphA8 expression construct were treated with PI-PLC to eliminate GPI-linked ephrin A subgroup ligands from the cell surface, followed by incubation with or without preclustered ephrin A5-Fc for a further 30 min. Consistent with our previous reports, tyrosine phosphorylation in EphA8 was significantly more enhanced by ephrin A5-Fc, regardless of PI-PLC treatment ( Figure 5a , first and second panels, lanes 2 and 4) (Park and Sanchez, 1997; . Next, we assessed MAPK activation in vector-or EphA8-transfected NIH3T3 cells by Western blot analysis of cell lysates, Elk-1 luciferase activity in EphA8-transfected cells was observed irrespective of ephrin-A5 stimulation, and activity levels were similar to those observed in NIH3T3 cells transfected with a constitutively active mutant of MEK1, MEK2E ( Figure 5b , lanes 3-6), whereas the luciferase induction by EphA8 was markedly suppressed by PD98059 treatment (lane 4). This result that sustained MAPK activation is induced by the expression of EphA8 with no requirement of ligand stimulation was also reproducibly observed in NIH3T3 fibroblasts stably expressing the EphA8 receptor or kinase-inactive EphA8 mutant (data not shown). Similar experiments were performed in transiently transfected HEK293 cells to determine whether EphA8 is capable of activating MAPK in this cell type. As EphA8 induces sustained ligand-independent increase in MAPK activation in both NIH3T3 fibroblasts and HEK293 epithelial cells. (a) NIH3T3 cells transiently transfected with the EphA8 expression construct were treated with preclustered ephrin A5-Fc and PI-PLC, as described previously (Park and Sanchez, 1997) . At 48 h post-transfection, equal amounts of proteins (500 mg) from cell lysates were immunoprecipitated with anti-EphA8 antibodies, and analysed by immunoblotting with anti-phosphotyrosine antibodies as a probe (first panel). The same blot was stripped and reprobed with anti-EphA8 antibodies (second panel). NIH3T3 cells were transiently transfected with pcDNA3-neo vector as a control or wild-type EphA8 expression construct, and treated with preclustered ephrin A5-Fc and PI-PLC, as described in the top panel. Equal amounts of proteins (100 mg) from cell lysates were directly analysed by immunoblotting with anti-phospho MAPK antibodies (third panel). The same blot was stripped and reprobed with anti-MAPK antibodies (fourth panel). (b) NIH3T3 cells were transfected with vector or EphA8 expression construct, together with a mixture containing pFR-Luc plasmids, pFA2-Elk1 plasmids, and pCMV-bGal plasmids (internal control). The pFC-MEK1 plasmid containing the constitutively active MEK mutant was used as a positive control. At 24 h post-transfection, cells were treated ( þ ) with preclustered ephrin A5-Fc for 30 min or left untreated (À). Luciferase activity was measured using a luminometer, and normalized to bgalactosidase activity determined from the same lysates. Data are presented as means7s.e. from three independent experiments. (c) HEK293 cells were transiently transfected with pcDNA3-neo vector as a control or wild-type EphA8 expression construct, and treated ( þ ) with preclustered ephrin A5-Fc for 30 min or left untreated (À), as described previously (Gu and Park, 2001) . At 48 h posttransfection, equal amounts of proteins (500 mg) from cell lysates were immunoprecipitated with anti-EphA8 antibodies, and analysed by immunoblotting with anti-phosphotyrosine antibodies as a probe (first panel). The same blot was stripped and reprobed with antiEphA8 antibodies (second panel). Equal amounts of proteins (100 mg) from each cell lysate sample were directly analysed by immunoblotting with anti-phospho MAPK antibodies (third panel). The same blot was stripped and reprobed with anti-MAPK antibodies (fourth panel). (d) HEK293 cells were transiently transfected with EphA8 expression vector and trans-reporting plasmids, and the luciferase assay was performed, as described in panel b. Data are presented as means7s.e. from three independent experiments. (e) Equal amounts of proteins (100 mg) from each cell lysate sample were directly analysed by immunoblotting with antiphospho MAPK antibodies (first panel) or a mixture containing both anti-EphA8 and anti-TrkB antibody (third panel). The same blot shown in the first panel was stripped and reprobed with anti-MAPK antibodies (second panel) Induction of neurite outgrowth by the EphA8 receptor C Gu et al shown in Figure 5c , in contrast to NIH3T3 cells, tyrosine phosphorylation levels in EphA8 were not significantly altered upon treatment with preclustered ephrinA5-Fc, compared to that in the absence of ephrin-A5 stimulation (first and second panels). However, analogous to data obtained with NIH3T3 cells, MAPK phosphorylation was significantly higher in EphA8-transfected HEK293 cells, irrespective of ephrin-A5 stimulation (Figure 5c , third and fourth panels, lanes 3 and 4). In addition, an Elk-1 trans-reporting assay confirmed that transient expression of EphA8 in HEK293 cells led to an approximate threefold increase in Elk-1 luciferase activity, regardless of ephrin-A5 stimulation (Figure 5d ), although this effect was significantly less than that of MEK2E (15-fold increase compared to control). In addition, the luciferase induction by EphA8 was markedly suppressed by PD98059 treatment (lane 4). Similar results were also observed in HEK293 cells stably expressing the EphA8 receptor or kinase-inactive EphA8 mutant (data not shown). The EphA8-induced MAPK activation was to a lesser degree as compared to the EphA8-TrkB chimeric receptor-induced MAPK activation in both NIH3T3 cells and HEK293 cells (Figure 5e ). It is likely that this reduced level of MAPK activation resulted from the lower expression level of the EphA8 receptor ( Figure 5e , third panel). Our data clearly indicate that the ligand-engaged activation of the EphA8 receptor has no effect on Induction of neurite outgrowth by the EphA8 receptor C Gu et al transient modulation of MAPK activation in our cell culture system. It is possible that the EphA8 receptor is maximally active due to overexpression and thus not responsive to ephrinA5-Fc in both NIH3T3 and HEK293 cells. To rule out this possibility, we used a doxycycline-inducible expression system for the wildtype or kinase-inactive EphA8 receptor in HEK293 cells as described previously (Gu and Park, 2001) . In this system, no EphA8 was detected in the absence of doxycycline, and the level of EphA8 expression correlated with the time of incubation with doxycycline (Figure 6a, first panel) . At each EphA8 expression time point, tyrosine phosphorylation of EphA8 was not significantly altered by ephrinA5-Fc (data not shown). As expected, significant increase in MAPK phosphorylation was observed in a correlation with the expression level of EphA8, but not affected by ephrin-A5 stimulation (Figure 6a , second, third, and fourth panels). Consistent with results obtained with the phosphospecific MAPK antibody, significant increase in transacting activity of Elk-1 was also observed in a correlation with the expression level of EphA8, but not affected by ephrin-A5 stimulation (Figure 6b ). In response to doxycycline, time-dependent induction of the kinase-dead EphA8 mutant and MAPK activation profiles were very similar to the patterns observed for the wild-type EphA8 receptor, and this effect was irrespective of ephrin-A5 stimulation (Figure 6c and  d) . As expected, no tyrosine phosphorylation of the mutant EphA8 protein was detectable (data not shown). Expression levels of the wild-type EphA8 receptor in Dox-inducible HEK293 cells were approximately 30-fold lower at 6 h and sixfold lower at 24 h than that shown following transient transfection (Figure 6e and f) .
Finally, MAPK activity was measured in NG108-15 cells (Figure 7) . Treatment of EphA8-transfected cells with ephrinA5-Fc induced a slight increase (approximately 1.5-fold) in EphA8 tyrosine phosphorylation (first panel, lanes 3 and 4). Analogous to data obtained with NIH3T3 and HEK293 cells, MAPK activity was strongly enhanced (4-5-fold increase, compared to the control for p42-MAPK) in EphA8-transfected NG108-15 cells, irrespective of ephrin-A5 stimulation (Figure 7a ). Consistent with data from Figure 2b , the EphA8 mutant lacking a highly conserved tyrosine kinase domain was less efficient in activating MAPK in NG108-15 cells, since MAPK activity induced by the deletion mutant was approximately twofold lower than that by wild-type or kinase-inactive EphA8 (Figure 7b , second, third and fourth panels). To assess whether the effects of EphA8 on MAPK and neurite outgrowth stimulation were also shown by other neuronal cell lines, Neuro2a cells were transiently transfected with EGFP or EphA8-IRES-EGFP (Figure 7c ). The transfection efficiencies were approximately 25% based on the relative numbers of GFP-positive cells. Analogous to data obtained from NG108-15 cells, the treatment of EphA8-transfected cells with ephrinA5-Fc induced a significant increase in EphA8 tyrosine phosphorylation (first and second panels). In addition, both MAPK activity (fivefold increase) and the percentage of neuritebearing cells (fourfold increase (n ¼ 500)) was significantly enhanced in EphA8-transfected Neuro2a cells, irrespective of ephrin-A5 stimulation (Figure 7c and d) . To address the issue of the functional differences between EphA8 and EphB2 in NG108-15 cells, we generated NG108-15 cells stably expressing EphB2. As shown in Figure 7e , the activation of EphB2 in NG108-15 cells strongly inhibited MAPK activity. Consistent with previous reports (Elowe et al., 2001; Tong et al., 2003) , we confirmed that ligand-activated EphB2 induces neurite retraction in NG108-15 cells (data not shown). To further address the issue as to whether the EphA8 kinase-dead mutant can activate MAPK by being recruited into activated receptor complexes, we performed transient transfection with the control EGFP vector, wild-type EphA8, or kinase-inactive K666 M EphA8 into NG108-15 cells, and the cells were then treated with preclustered ephrinA5-Fc for 30 min. A Western blot analysis of total cell lysates was performed with anti-phosphotyrosine antibody as a probe. As shown in Figure 8a , tyrosine phosphorylation of other proteins was not significantly increased in response to EphA8 expression in NG108-15 cells. We further performed a time-course experiment of ephrin-A5 stimulation in the EphA8-transfected NG108-15 cells. As shown in Figure 8b and c, expression of EphA8 in NG108-15 cells resulted in a significant increase in MAPK activity and their levels were comparable to that observed in serum-stimulated control cells (compare lanes 1-3). However, transient activation or inhibition of MAPKs was not observed within 2-120 min of ephrin-A5 stimulation (lanes 4-8). In addition, in EphA8-transfected NG108-15 cells, expression of phospho-MAPKs and EphA8 protein increased at 24 h after transfection and these elevated levels were maintained from 24 to 72 h (data not shown). Immunofluorescence microscopy analyses of MAPK subcellular localization revealed that MAPKs relocalized from the cytoplasm to the nucleus in 35-40% of wild-type or kinase-inactive EphA8-transfected cells, compared to only 10% of cells expressing the kinase domain deletion EphA8 mutant (Figure 8e ). In EGFP vector-transfected control cells, we observed no nuclear staining of MAPKs (Figure 8d, top panels) . Taken together, we conclude that expression of EphA8 is sufficient to induce sustained activation of MAPKs, thereby leading to neuronal differentiation.
Discussion
In the present study, we demonstrate that the EphA8 receptor plays an important role in inducing neuronal cell differentiation through MAPK activation. A novel finding in the present investigation is that expression of EphA8 in NG108-15 neuroblastoma cells is sufficient per se to induce MAPK activation and neurite outgrowth. Significantly, ligand-mediated stimulation of EphA8 does not further promote its ability to induce MAPK activation in any of the cell types The wild-type EphA8 receptors in HEK293 cells were inducibly expressed with doxycyclin (2 mg/ml) for the indicated times, and then treated with ( þ ) preclustered ephrin A5-Fc for 30 min or left untreated (À), as described previously (Gu and Park, 2001 ). Equal amounts of protein (100 mg) from cell lysate were directly analysed by immunoblotting with anti-EphA8 antibody (first panel). Equal amounts of protein (100 mg) from cell lysate were analysed by immunoblotting using anti-phospho MAPK antibodies (second panel). The same blot was stripped and reprobed with anti-MAPK antibodies (third panel). Densitometry analyses using RAS 3000 (Fuji) are depicted as the relative ratio of phosphorylated p42 to total p42 MAPK (fourth panel). Data are presented as means7s.e. from three independent experiments. (b) HEK293 cells expressing induced wild-type EphA8 were transiently transfected with trans-reporting plasmids and cultured under same the conditions as described above. The luciferase assay was performed, as described in the legend for Figure 5d . (c, d) Experiments were performed essentially as described in panels a and b, except that the kinase-inactive K666M EphA8 receptor was inducibly expressed instead of the wild-type EphA8 receptor. (e) Comparison of EphA8 expression levels from transiently transfected cells versus inducibly expressed cells. Equal amounts of protein (50 mg) from cell lysate were analysed by immunoblotting using antiEphA8 antibodies (first panel). The same blot was stripped and reprobed with anti-b1 integrin antibodies (second panel). (f) Densitometric values obtained using RAS3000 are depicted as relative ratios of total EphA8 protein to b1 integrin protein Induction of neurite outgrowth by the EphA8 receptor C Gu et al Figure 7 EphA8 induces a sustained increase in MAPK activation in NG108-15 cells with no requirement for ligand stimulation. (a) NG108-15 cells were transiently transfected with EGFP or EphA8-IRES-EGFP, as described for Figure 1a , and treated ( þ ) with preclustered ephrin A5-Fc for 30 min or left untreated (À). Equal amounts of proteins (500 mg) from each cell lysate sample were immunoprecipitated with anti-EphA8 antibodies, and analysed by immunoblotting with anti-phosphotyrosine antibodies as a probe (first panel). The same blot was stripped and reprobed with anti-EphA8 antibodies (second panel). Equal amounts of proteins (100 mg) from each cell lysate sample were directly analysed by immunoblotting with anti-phospho MAPK antibodies (third panel). The same blot was stripped and reprobed with anti-MAPK antibodies (fourth panel). Densitometry analyses using RAS 3000 (Fuji) are depicted as the relative ratio of phosphorylated p42 to total p42 MAPK (fifth panel). (b) NG108-15 cells were transiently transfected with EGFP or each of the individual EphA8 cDNA variants, as described for Figure 2a . Equal amounts of proteins (100 mg) from each cell lysate sample were directly analysed by immunoblotting with anti-EphA8 (first panel) or anti-phospho MAPK antibody (second panel). The blot shown in the second panel was stripped and reprobed with anti-MAPK antibody (third panel). Densitometry analyses using RAS 3000 (Fuji) are depicted as the relative ratio of phosphorylated p42 to total p42 MAPK (fourth panel). (c) Neuro2a cells were transiently transfected with EGFP or EphA8-IRES-EGFP, and immunoprecipitation and immunoblotting were performed essentially as described in Figure 7a . (d) Neurite-bearing cells identified by GFP expression were quantified as described in Figure 1a , except that cells containing neurites exceeding one cell body diameter in length were counted as neurite-bearing cells. At least 500 GFP-positive cells were scored for each condition. Data are presented as means7s.e. from at least three independent experiments. b , Po0.005 compared with cells transfected with EGFP. (e) The activation of EphB2 inhibits MAP kinase activity in NG108-15 cells. Wild-type murine EphB2 cDNA was stably transfected into NG108-15 cells as described previously (Holland et al., 1997) . Experiments were performed essentially as described in panel a, except that anti-EphB2 antibody was used for immunoprecipitation and immunoblotting Induction of neurite outgrowth by the EphA8 receptor C Gu et al examined. Additionally, while the tyrosine kinase activity of EphA8 is not crucial for MAPK activation and neurite outgrowth, the tyrosine kinase domain of EphA8 itself is important for mediating these effects in NG108-15 cells. It is therefore possible that the EphA8 kinase domain is an important binding site of molecules critical for activating the MAPK signaling pathway. However, we found that the EphA8 kinase domain alone did not induce neurite outgrowth in NG108-15 cells, suggesting a supplementary role of its neighboring regions. These findings raise several important issues including: (i) the mechanism by which the EphA8 receptor induces a sustained MAPK activation with no requirement for ligand stimulation, (ii) the mechanism by which the EphA8 receptor stimulates MAPK activation and neurite outgrowth in its tyrosine kinase activity-independent manner, (iii) the physiological relevance of the EphA8-induced MAPK The first issue concerns how the EphA8 receptor induces a sustained MAPK activation in the absence of ligand stimulation. Our current data clearly indicate that the pattern of MAPK activation corresponds to the expression of EphA8 receptor rather than ephrin-A5 stimulation. These findings contradict previous reports that the ligand-mediated stimulation of Eph family kinases negatively (Elowe et al., 2001; Miao et al., 2001) or positively (Pratt and Kinch, 2002; Vindis et al., 2003) regulates rapid and transient alteration of MAPK activation. There are a number of potential explanations for these discrepancies, including different cell types, assay conditions, and Eph genes used. However, we do not favor the cell type-dependency as the explanation, since EphA8 induced sustained activation of MAPKs in at least three different cell types identically. It may also be argued that the EphA8 receptor is maximally autoactivated due to overexpression in our cell culture system and thus rendering the cells nonresponsive to the ligand. This argument may be partly consistent with our observation that the level of ligand-induced tyrosine phosphorylation of EphA8 is not significantly different from that in unstimulated conditions in NG108-15 or HEK293 cells. However, a treatment with preclustered ephrinA5-Fc stimulates the migration of HEK293 cells transiently expressing the wild-type or kinase-inactive EphA8 receptor on fibronectin substrate as previously described . These results clearly indicate that the EphA8 receptor influences cell behavior in response to the ligand stimulation. Additionally, in our conditional expression system, a gradual increase of the EphA8 protein level in HEK293 cells resulted in a significant increase of MAPK activation. In contrast, MAPK phosphorylation was not significantly altered by ephrin-A5 stimulation regardless of the level of EphA8 receptor expression as shown in Figure 6 . These results support the notion that the EphA8 receptor is sufficient to induce a prolonged increase in MAPK activation without ligand stimulation. To completely rule out the argument that the EphA8 receptor is not responsive to ligand due to overexpression, it may be necessary to use the NG108-15 cells stably expressing the EphA8 receptor at a low level. We have found it difficult to make NG108-15 cells stably expressing the EphA8 receptor most likely because the EphA8 receptor induces neuronal differentiation through a sustained MAPK activation in this cell type. Alternatively, it may be more physiologically relevant to use a neuronal cell line in which the EphA8 receptor is endogenously expressed. However, when we cultured primary tectal cells using a conventional primary neuronal cell culture system, the expression of the EphA8 receptor disappeared 2-3 days after the onset of in vitro culture.
The next question concerns the mechanism by which the EphA8 receptor induces a sustained MAPK activation and neurite outgrowth in an autokinase activityindependent manner. Our data clearly demonstrate that the tyrosine kinase activity of the EphA8 receptor has no correlation with its ability to stimulate either the MAPK activation or neurite outgrowth. It may be argued that reverse signaling via endogenous GPI-linked ephrins directly promotes either MAPK activation or neurite outgrowth. However, we find this hypothesis is unlikely to be true based on the following three reasons. Firstly, treatment with oligomerized EphA8-Fc (the ectodomain of EphA8 fused to the Fc portion of IgG 1 ) (Park and Sanchez, 1997) does not induce MAPK activation in the three different cell types examined in the present study (Gu and Park, unpublished results) . Secondly, unlike EphA8, expression of ephrin-A5 in NG108-15 cells does not induce neurite outgrowth, regardless of treatment with oligomerized EphA8-Fc. Thirdly, NIH3T3 and HEK293 cell lines stably expressing ephrin-A5 do not display MAPK activation whether in the presence or absence of oligomerized EphA8-Fc. In addition, ephrin-A type ligands were barely detectable in both HEK293 and NG108-15 cells as estimated by binding to EphA8-Fc. The mechanism by which EphA8 induces MAPK activation and neurite outgrowth in tyrosine kinase activity-independent manner remains to be elucidated in our future work. Interestingly, a recent report demonstrates that a complete abrogation of all RasGAP-binding sites of EphB2, accompanied by the addition of a Grb2-binding site, leads to activation of MAPKs following ephrin-B1 stimulation instead of downregulation of the Ras-MAPK signaling pathway (Tong et al., 2003) . The data strongly suggest that distinct Eph receptors transmit opposite signals to the MAPK pathways through their ability to recruit distinct targets. In this respect, the ability to induce prolonged MAPK activation may be attributed to a structural feature unique to the EphA8 receptor. One possibility is that the EphA8 receptor may contain unique structural features to spontaneously form a multimerized complex in the absence of ligand. This complex may induce other receptor tyrosine kinases to cluster with it and activate their phosphorylation signaling cascade leading to the MAPK activation. Although we do not entirely rule out this possibility, our phosphotyrosine blots on whole-cell lysates do not support this possibility because marked increase in tyrosine phosphorylation of other proteins was not observed in response to EphA8 expression. Alternatively, integrins or G-protein-coupled receptors may be clustered with the EphA8 receptor, although this remains to be shown in our future work. In addition, to elucidate the mechanism by which the EphA8 receptor regulates MAPK signaling in a tyrosine kinase activityindependent manner, the identification of signaling proteins downstream of EphA8 is important. Although p110g PI-3 kinase is critical for EphA8-mediated cell adhesion (Gu and Park, 2001 ) and migration independent of EphA8 autokinase activity, this lipid kinase may not be involved in EphA8-induced MAPK activation and neurite outgrowth since its inhibitor, Wortmannin, does not impair this signaling process.
The final issue is the biological and physiological relevance of EphA8-stimulated MAPK activation for neuronal cell differentiation in vivo. The ability of nerve growth factor to induce sustained activation of MAPK has been implicated in PC12 cell neuronal differentiation (Vaudry et al., 2002) . Consistent with this theory, we show that the EphA8 receptor induces a prolonged increase in MAPK activation, leading to neurite outgrowth in NG108-15 cells. The EphA8-mediated signaling pathway has been shown to regulate numerous biological processes, including axonal pathfinding in mice, cell adhesion, and cell migration in cultured cells Park, 2001, 2003) . In this respect, our current findings about EphA8 add another biological activity to the list, namely neuronal differentiation. The EphA8 gene is predominantly expressed in the rostral region of the developing midbrain, whereas many ephrin-A ligands are exclusively present in the caudal region of the developing midbrain (Koo et al., 2003) . Such complementary expression of Eph receptors and ephrins in the developing tectum suggests a role for these proteins in regionalization of the tectum. In the rostral region of the developing midbrain, the EphA8 receptor may be involved in inducing neuronal differentiation of tectal cells through sustained activation of the MAPK signaling pathway. While the EphA8 receptor facilitates the development of axonal projections, ephrin ligands may regulate axonal pathfinding through interactions with the EphA8 receptor. This hypothesis remains to be tested at least in a primary tectal cell culture system. As described above, downregulation of the EphA8 receptor gene expression in primary tectal cells has been the main technical difficulty in demonstrating this hypothesis. Nevertheless, our findings suggest that the EphA8 receptor has multifunctional aspects during the development of the nervous system. In the absence of ligands, the juxtamembrane region and tyrosine kinase domain of EphA8 trigger intracellular signaling pathways leading to increased cell adhesion and induction of neurite outgrowth, respectively. In the presence of ligands, the EphA8 receptor may regulate cell migration or behavior of the axonal growth cone.
Materials and methods
Cell culture, transfection, and reagents NG108-15 cells were cultured in DMEM (Sigma) containing 10% fetal bovine serum (BioWhittaker) and HAT (100 mM hypoxanthine, 1 mM aminopterin, and 16 mM thymidine) (Invitrogen), as described previously (Nelson et al., 1976) . Neuro2a cells were cultured in DME/F12 (HyClone) containing 10% fetal bovine serum (BioWhittaker). NIH3T3 and HEK293 cells were cultured as described previously (Park and Sanchez, 1997; . Transient transfection procedures were performed using LipofectAMINE (Invitrogen), according to the manufacturer's instructions. Doxycycline-inducible EphA8 expression cell lines were culture as described previously (Gu and Park, 2001) . Stable transfection of murine EphB2 cDNA into NG108-15 cells was performed as described previously (Holland et al., 1997) .
For treatment with preclustered ephrinA5-Fc or ephrinB1-Fc proteins, purified Fc fusion protein (1 mg/ml) was aggregated with anti-human Fc (Jackson Immunoresearch) for 30 min on ice, and stimulated for 30 min at 371C . Cells were treated with the following reagents: dbcAMP (0.25 mM), 8-Bromo-cAMP (adenosine 3 0 ,5 0 -cyclic monophosphate, 8-Bromo-, 0.25 mM), Rp-cAMP (adenosine 3 0 ,5 0 -cyclic monophosphorothioate, 20 mM), 5-24 protein kinase A inhibitor (5 mM), PD98059 (25 mM), U0126 (300 nM), and Wortmannin (100 nM).
Expression vectors and luciferase assay
Murine wild-type, kinase-inactive (K666M), JM region-deleted, and SAM-deleted EphA8 cDNA constructs tagged with the nine amino-acid HA epitope (YPYDVPDYA) at the COOH termini have been described elsewhere (Gu and Park, 2001) . To construct the kinase domain-deleted EphA8 mutant, a 425 bp PCR product was obtained using primers corresponding to nucleotides 1570-1589 and 1977-1995 of the insert in pSP38. A 360 bp PCR product was generated using primers corresponding to nucleotides 2731-2750 and 3072-3090 of the insert in pSP38. The partially complementary fragments generated by these PCR products were annealed and reamplified with primers specific for the 5 0 end of the first product and 3 0 end of the second PCR product. The resulting 771 bp product was digested with BamHI and BssHII, and subcloned into the corresponding sites of full-length EphA8 cDNA. Each individual EphA8 cDNA insert described above was subcloned into the pIRES2-EGFP vector (Clontech) using EcoRI. MEK2A, a dominant-negative mutant of MEK, has been described elsewhere (Yan and Templeton, 1994; Kuo et al., 1996) . To evaluate MAPK activation, an expression vector encoding the Gal4-DNA-binding domain (dbd)-Elk1 protein was cotransfected with the EphA8 expression construct, pFRLuc reporter plasmid, and pCMV-b-gal into cells. An MEK1 constitutively active mutant, pFC-MEK1, was employed as the positive control. At 24 h post-transfection, cells were harvested for the luciferase assay, as described previously (Jeong et al., 2000) .
Neuronal differentiation
For analysing neuronal differentiation, cells were plated (3 Â 10 5 cells per 60 mm dish) and transiently transfected with individual EphA8 variants subcloned into the pIRES2-EGFP vector. At 24 h post-transfection, cells (2 Â 10 4 ) were seeded into coverslips coated with fibronectin. After 48 h, green fluorescent cells were observed under a fluorescence microscope (Olympus, IX71 model). Cells containing neurites at least one cell body diameter (for Neuro2a cells) or three cell body diameters (for NG108-15 cells) in length were scored as neurite-bearing cells. Transfected cells that grew neurites were normalized to the number of total green fluorescent cells, and presented as a percentage. For each transfectant, at least 500 transfected cells were counted. Data points are presented as the mean7s.e. of at least three independent experiments.
Immunoprecipitation, Western blotting, binding assay, and immunofluorescence staining
Immunoprecipitation and Western blot analysis using antiEphA8 or anti-phosphotyrosine antibody were performed as described previously . For Western blots of MAPK and phospho-MAPK, experiments were performed according to the procedure used for anti-phosphotyrosine antibody. Protein concentrations of cleared lyastes were determined using a Bradford assay (BioRad), where indicated. Cell surface-binding assay using ephrinA5-Fc was performed as described previously (Park and Sanchez, 1997) .
For immunostaining of NG 108-15 cells with anti-MAPK antibodies, cells were plated (3 Â 10 5 cells per 60 mm dish) and transiently transfected with an IRES-EGFP vector containing the indicated cDNA inserts. At 24 h post-transfection, cells were seeded into coverslips coated with fibronectin. After 48 h, cell were washed once in PBS, fixed with 3% paraformaldehyde in PBS for 30 min at 41C, and rinsed three times for 5 min each with TBST (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Triton X-100). Cells were refixed in 100% methanol at À201C for 10 min, and rinsed three times for 5 min with TBST before blocking for 1 h at room temperature with TBST containing 5% normal horse serum. Fixed cells were incubated with anti-MAPK2 (Erk-2) antibodies (1 : 400) overnight at 41C in TBST containing 5% BSA. Cells were washed once for 15 min with TBST, and rewashed once for 15 min with 0.1% BSA in TBST. After washing, cells were incubated with Texas red-conjugated antimouse antibodies (1 : 500) in TBST containing 3% BSA for 60 min at room temperature. Finally, cells were washed three times for 5 min each with TBST. For analysing the nuclear localization of endogenous MAPK, the nucleus was stained with Bisbenzimide (Hoechst 33258, 1 : 1000) in PBS for 2 min at room temperature, and cells were observed under a fluorescence microscope (Olympus, IX71 model). Nuclear translocation of MAPK was assessed by counting the cells with nuclear localized MAPKs among GFP-positive cells (n ¼ 200).
Antibodies
The polyclonal rabbit antibody specific for the JM domain of EphA8 is described in a previous report . The monoclonal anti-phosphotyrosine antibody was obtained from (4G10) Upstate Biotechnology. Monoclonal anti-phospho-MAPK and polyclonal anti-MAPK antibodies were from Cell Signaling Technologies. Monoclonal anti-EphB2 antibody was from R&D Systems. The monoclonal anti-MAPK2 (Erk-2) antibody used for immunofluorescence staining was purchased from Santa Cruz Biotechnology, polyclonal anti-GFP antibody from Clontech, HRP-conjugated secondary antibodies from Amersham Pharmacia Biotech, and Texas red-conjugated anti-mouse antibody from Vector Laboratories. Bisbenzimide (Hoechst 33258) was acquired from Molecular Probes.
